Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
6.66
-0.26 (-3.76%)
At close: Mar 23, 2026, 4:00 PM EDT
6.66
0.00 (0.00%)
After-hours: Mar 23, 2026, 4:00 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $64.2 million as of March 23, 2026. Its market cap has decreased by -16.73% in one year.
Market Cap
64.20M
Enterprise Value
-77.38M
1-Year Change
-16.73%
Ranking
Category
Stock Price
$6.66
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $64.20M, a decrease of -78.72%. That is a compound annual growth rate of -24.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 74.38M | -12.59% |
| Dec 31, 2025 | 85.10M | -2.63% |
| Dec 31, 2024 | 87.39M | 7.13% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 72.87M |
| iBio, Inc. | 72.20M |
| Gain Therapeutics | 70.39M |
| Coeptis Therapeutics Holdings | 70.32M |
| Pelthos Therapeutics | 69.59M |
| Grace Therapeutics | 68.40M |
| InflaRx | 67.96M |
| BeyondSpring | 64.53M |